Pain managementJul 15, 2026

Combining high-dose ketamine, psychological support, and specialized pain care for hard-to-treat pain conditions

Psychedelic Science Weekly Brief ↗PubMed ↗DOI ↗

Updated Jul 16, 2026

Abstract

In 2023, the Ketamine Infusion Pain Program (KIPP) was formally established at Toronto Western Hospital to provide high dose ketamine infusions for refractory pain syndromes.

Ketamine is administered intravenously at a dosage of 0.5 mg/kg as a bolus, followed by an infusion of up to 1 mg/kg/hr for six hours.
The program incorporates multidisciplinary services, including psychology support aimed at education and post-ketamine integration.
Data is being collected on pain, psychological factors, sleep, and functioning before and after high dose ketamine infusions.
Future plans involve refining dosing protocols, exploring co-administration with other medications, and enhancing support services.

Simplified

Ketamine is a noncompetitive antagonist of the N-methyl-D-aspartate receptor that has garnered significant interest as a treatment for both chronic pain and mental health symptoms in the last two decades. The authors introduce the methodological framework of the Ketamine Infusion Pain Program (KIPP) at Toronto Western Hospital (TWH) and outline a high dose ketamine infusion (HDKI) regimen for refractory pain syndromes implemented through an innovative multidisciplinary care model. HDKIs have been offered at TWH since 2010 and in 2023, the KIPP was formally established and reconceptualized to include multidisciplinary services. The redesign included peri-ketamine psychology services to provide education, support, and post-ketamine integration, and to optimize adaptive behaviors in the post-ketamine period. At KIPP, ketamine (0.5 mg.kg^-1) is provided intravenously as a bolus, followed by an infusion dose up to 1 mg^-1.kg.hr^-1 IV for six hours. The KIPP is collecting data on pain, psychological factors, sleep, and functioning pre- and post-HDKI to evaluate patient outcomes, which will be presented in a future article. Future directions include further refinement of dosing protocols and co-administration of other medications and the expansion of peri-infusion psychology services with increased focus on preparation and integration, as well as the evaluation of these initiatives.

Full Text

Full text is available at the source.

View Full Text ↗

Combining high-dose ketamine, psychological support, and specialized pain care for hard-to-treat pain conditions

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the psychedelic science brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the psychedelic science brief